← SynDRA
CPI-1205
SynDRA canonical compound SYN0039611 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | EZH2 |
| Mechanism of action | EZH2 inhibitor |
All known targets
Mechanisms of action (all sources)
Drug classes
Cross-references
Synonyms
- CPI 1205
- LIRAMETOSTAT
- EZH2 INHIBITOR CPI-1205
- CPI1205
- GTPL9115
- LIRAMETOSTAT (CPI-1205)
- SCHEMBL17329268
- HPODOLXTMDHLLC-QGZVFWFLSA-N
- UNII-455J2479FY
- 455J2479FY
- (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
- MolPort-044-560-382
- KS-000006BA
- EX-A1068
- s8353
- AKOS030628484
- ZINC220982768
- CS-7648
- compound 13 [PMID: 27739677]
- HY-100021
- J3.556.402K
- N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-
- Lirametostat
- Ezh2 inhibitor cpi-1205
- RefChem:128349
- LIRAMETOSTAT [INN]
- LIRAMETOSTAT [WHO-DD]
- orb1298870
- SCHEMBL29361104
- C27H33F3N4O3
- GLXC-10078
- WPC86270
- BDBM50541920
- MFCD30470657
- NSC793430
- CCG-269843
- EBC-420052
- NSC-793430
- SB19773
- NCGC00507883-02
Look up CPI-1205 in the interactive SynDRA portal →